File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study
Title | HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study |
---|---|
Authors | |
Issue Date | 2021 |
Citation | Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology, v. 74 n. S1, p. 65A- 66A How to Cite? |
Persistent Identifier | http://hdl.handle.net/10722/318052 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yuen, RMF | - |
dc.contributor.author | Ma, XL | - |
dc.contributor.author | Hassanein, TI | - |
dc.contributor.author | Kwo, PY | - |
dc.contributor.author | Ma, J | - |
dc.contributor.author | Li, L | - |
dc.contributor.author | Kitrinos, K | - |
dc.contributor.author | Knox, SJ | - |
dc.contributor.author | Stamm, LM | - |
dc.contributor.author | Bae, H | - |
dc.contributor.author | Sulkowski, MS | - |
dc.contributor.author | Elkhashab, M | - |
dc.contributor.author | Agarwal, K | - |
dc.date.accessioned | 2022-10-07T10:31:50Z | - |
dc.date.available | 2022-10-07T10:31:50Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology, v. 74 n. S1, p. 65A- 66A | - |
dc.identifier.uri | http://hdl.handle.net/10722/318052 | - |
dc.language | eng | - |
dc.relation.ispartof | Oral presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology | - |
dc.title | HBV PGRNA and DNA both rebound immediately following discontinuation of the core inhibitor vebicorvir despite continued nrti treatment in patients with HBeAg positive chronic hepatitis B virus infection: findings from a phase 2 open label study | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Yuen, RMF: mfyuen@hku.hk | - |
dc.identifier.authority | Yuen, RMF=rp00479 | - |
dc.identifier.hkuros | 338085 | - |
dc.identifier.volume | 74 | - |
dc.identifier.issue | S1 | - |
dc.identifier.spage | 65A | - |
dc.identifier.epage | 66A | - |